Viewing Study NCT00001761


Ignite Creation Date: 2025-12-24 @ 12:55 PM
Ignite Modification Date: 2025-12-29 @ 1:40 PM
Study NCT ID: NCT00001761
Status: COMPLETED
Last Update Posted: 2008-03-04
First Post: 1999-11-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module